SNWV News and Press, Sanuwave Health Inc From 03/22/24

2024-03-22 13:17:11 ET SANUWAVE Health Inc. (SNWV) Q4 2023 Results Conference Call March 22, 2024 8:30 AM ET Company Participants Morgan Frank - CEO & Chairman Toni Rinow - Chief Financial Officer Conference Call Participants Candace Laryea - MD Catas...

2024-03-22 07:26:07 ET More on SANUWAVE Health SEP Acquisition shareholders approve Sanuwave SPAC merger Sanuwave Health sees Q4 record revenue $6.6M-$6.8M, up 20% Y/Y Financial information for SANUWAVE Health Read the full article on Seeking Alpha Fo...

Q4 2023 revenues were a record $7.0 million, up 27% from Q4 2022 FY 2023 revenues were a record $20.4 million, up 22% from FY2022 Operating income was $1 million for Q4 2023 compared to an operating loss of $1.5 million for Q4 2022 Company provides guidance for revenue g...

Sanuwave Health Inc (SNWV) is expected to report for quarter end 2023-12-31

EDEN PRAIRIE, MN  - ( NewMediaWire ) - March 20, 2024 -  SANUWAVE Health, Inc. (the "Company" or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, March 22, 2024, at 8:30 AM (ET) to pre...

At a special meeting of stockholders on February 21, 2024, SANUWAVE stockholders approved the business combination with SEP Acquisition Corp. by a vote of 798,379,869 “for” and 5,221,765 “against” with 71,525 abstaining 70.5% of all shares eligible to vote in th...

2024-02-01 18:02:59 ET More on SEP Acquisition Corp., SANUWAVE Health, etc. Sanuwave Health sees Q4 record revenue $6.6M-$6.8M, up 20% Y/Y Financial information for SEP Acquisition Corp. Financial information for SANUWAVE Health Read the full article on See...

EDEN PRAIRIE, MN, Jan. 22, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced the Company is holding a special meeting...

2024-01-10 08:14:02 ET More on SANUWAVE Health Financial information for SANUWAVE Health For further details see: Sanuwave Health sees Q4 record revenue $6.6M-$6.8M, up 20% Y/Y

SANUWAVE is pleased to announce preliminary revenues of $6.6 million to $6.8 million for the fourth quarter ended December 31, 2023. This represents a new quarterly revenue record for the Company. Q4 2023 revenue increased 20% to 24% over Q4 2022 and in excess of 30% versus the third quart...